Effect of Adapted Physical Activity on Emotion Regulation in People With Depressive Disorders (REAPAD)
21 augusti 2026 uppdaterad av: Centre Hospitalier Georges Mazurelle
Impact d'un Programme d'activité Physique adaptée Sur la régulation Des émotions de Personnes Souffrant de Troubles dépressifs, en Sortie d'Hospitalisation : étude REAPAD
Depression is associated with difficulties in emotion regulation. Adapted physical activity (APA) may help improve emotional regulation in people with depressive disorders.
The REAPAD study evaluates the effects of an adapted physical activity program on emotion regulation in adults with depressive disorders following psychiatric hospitalization. Participants were randomly assigned to one of two APA programs: a standard adapted physical activity program or a combined adapted physical activity program including activities specifically targeting emotional regulation.
Emotion regulation is assessed using the Cognitive Emotion Regulation Questionnaire (CERQ). The study also evaluates depressive symptoms, anxiety, self-esteem, physical activity, physical condition, and other psychological and physical outcomes.
Studieöversikt
Status
Avslutad
Betingelser
Intervention / Behandling
Studietyp
Interventionell
Inskrivning (Faktisk)
45
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
Vendée
-
La Roche-sur-Yon, Vendée, Frankrike, 85 000
- EPSM de Vendée - Centre Hospitalier Georges Mazurelle
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Nej
Beskrivning
Inclusion Criteria:
- Age over 18 years
- Unipolar or bipolar depressive disorder
- Discharged from full hospitalization, up to three weeks after discharge
- Able to provide free and informed consent
- Not participating in any other research
Exclusion Criteria:
- High suicidal risk, at the investigator's discretion
- Medical contraindication to any physical activity
- Motor, psychological, or intellectual disability, or other medical condition, at the investigator's discretion, preventing full participation in the study
- Severe addictive disorder impeding participation in the study
- Psychotic disorder
- Pregnancy or breastfeeding
- Any circumstances rendering the participant unable to understand the nature, purpose, or consequences of the trial
- Under legal protection (guardianship or trusteeship)
- No social security coverage
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Classical Adapted Physical Activity
|
Participants received an individualized, moderate-intensity adapted physical activity program consisting of 8 sessions over 6 weeks, with at least one session per week.
The program included aerobic training (step-based exercises, lateral stepping and locomotor circuit tasks), lower-limb resistance training (chair stands, step-ups, lateral stepping and lunges), and agility and coordination exercises (agility ladder drills and motor circuit tasks).
Session duration progressively increased from 25 minutes for sessions 1 and 8 to 30, 35 and 40 minutes for the intermediate sessions.
Each session included a 5-minute warm-up and muscular flexibility period and a 10-minute cool-down period.
|
|
Experimentell: Combined Adapted Physical Activity Program
|
Participants received an individualized, moderate-intensity adapted physical activity program consisting of 8 sessions over 6 weeks, with at least one session per week.
The program included aerobic training, lower-limb resistance training, and agility and coordination exercises.
In addition, cognitive and emotional training tasks were integrated into the physical activity sessions.
Cognitive tasks included short-term memory activities, verbal fluency dual tasks and cognitive flexibility exercises.
Emotional tasks included identifying, recognizing and expressing emotions using images and photographs of facial expressions.
These cognitive and emotional tasks were incorporated during exercises and rest periods throughout the program.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in emotion regulation strategies assessed by the Cognitive Emotion Regulation Questionnaire (CERQ
Tidsram: Baseline (T0), immediately after completion of the 6-week intervention (T1), and 6 weeks after the end of the intervention (T2)
|
Emotion regulation strategies are assessed using the Cognitive Emotion Regulation Questionnaire (CERQ), a 36-item self-administered questionnaire comprising nine subscales.
Items are rated from 1 (almost never) to 5 (almost always), providing scores for adaptive and maladaptive cognitive emotion regulation strategies
|
Baseline (T0), immediately after completion of the 6-week intervention (T1), and 6 weeks after the end of the intervention (T2)
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in Depressive Symptom Severity Assessed by the Montgomery-Åsberg Depression Rating Scale (MADRS
Tidsram: Baseline (T0), immediately after completion of the 6-week intervention (T1), and 6 weeks after the end of the intervention (T2)
|
Depressive symptom severity is assessed using the Montgomery-Åsberg Depression Rating Scale (MADRS).
The scale consists of 10 items assessing depressive symptoms, each rated from 0 to 6.
The total score ranges from 0 to 60, with higher scores indicating greater severity of depressive symptoms.
|
Baseline (T0), immediately after completion of the 6-week intervention (T1), and 6 weeks after the end of the intervention (T2)
|
|
Change in Cognitive Flexibility Assessed by the Trail Making Test (TMT)
Tidsram: Baseline (T0), immediately after completion of the 6-week intervention (T1), and 6 weeks after the end of the intervention (T2)
|
Cognitive functioning is assessed using the Trail Making Test (TMT).
The test includes Part A and Part B. Performance is assessed using the time required to complete each part, with longer completion times indicating poorer performance.
|
Baseline (T0), immediately after completion of the 6-week intervention (T1), and 6 weeks after the end of the intervention (T2)
|
|
Change in Subjective Vitality Assessed by the Subjective Vitality Scale
Tidsram: Baseline (T0), immediately after completion of the 6-week intervention (T1), and 6 weeks after the end of the intervention (T2)
|
Subjective vitality is assessed using the Subjective Vitality Scale.
The scale consists of 5 items rated from 1 to 7 and assesses the participant's subjective experience of physical and psychological energy and vitality.
Higher scores indicate greater subjective vitality
|
Baseline (T0), immediately after completion of the 6-week intervention (T1), and 6 weeks after the end of the intervention (T2)
|
|
Change in Mood States Assessed by the Profile of Mood States (POMS-F)
Tidsram: Immediately before and immediately after each adapted physical activity session
|
Mood states are assessed using the French version of the Profile of Mood States (POMS-F), a 65-item self-administered questionnaire.
The questionnaire assesses seven transient and fluctuating mood dimensions: tension-anxiety, anger-hostility, confusion-bewilderment, depression-dejection, fatigue-inertia, vigor-activity, and interpersonal relations.
Items are rated on a 5-point Likert scale.
An overall psychological distress score is calculated by summing the tension-anxiety, anger-hostility, confusion-bewilderment, depression-dejection, and fatigue-inertia scores and subtracting the vigor-activity score.
Higher psychological distress scores indicate greater mood disturbance.
Mood state is assessed using the French version of the Profile of Mood States (POMS-F).
The POMS-F consists of 65 items rated from 0 (not at all) to 4 (extremely).
The Global Score is calculated as the sum of Anxiety-Tension, Anger-Hostility, Confusion-Bewilderment, Depression-Dejection, and Fatigue-Inertia scores
|
Immediately before and immediately after each adapted physical activity session
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Publikationer och användbara länkar
Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.
Allmänna publikationer
- Longuechaud C, Videau Villeneuve F, Bulteau F, Valot I, Douet M, Bulteau S, Deschamps T, Sauvaget A. The effect of adapted physical activity programs on the regulation of emotions in people suffering from major depressive disorders after hospital discharge: REAPAD study protocol. Minerva Psychiatry. 2026;67(2):82. doi:10.23736/S2724-6612.26.02669-2.
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
10 februari 2023
Primärt slutförande (Faktisk)
30 april 2026
Avslutad studie (Faktisk)
30 april 2026
Studieregistreringsdatum
Först inskickad
19 augusti 2026
Först inskickad som uppfyllde QC-kriterierna
19 augusti 2026
Första postat (Faktisk)
21 augusti 2026
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
24 augusti 2026
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
21 augusti 2026
Senast verifierad
1 augusti 2026
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 2022-A02099-34
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
NEJ
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .